E-ring modified steroids as novel potent inhibitors of 17β-hydroxysteroid dehydrogenase type 1

~89%

~%

~34%

~%

~63%

~%

~33%

~55%

~%

~41%

~%

~51%

~29%

~%

~%

~%

~35%

~60%